Novos Stock (NVOS): Price, Chart & Analysis Guide

A lot of people type “novos stock” into Google when they actually mean NVOS, the ticker for Novo Integrated Sciences, Inc. The extra “o” is a common typo, but the confusion is understandable. Novo Integrated Sciences trades on the OTC market under NVOS, and its price chart looks more like a heartbeat monitor than a normal equity. If you have landed here after searching “novos stock,” this guide covers what the company does, why the share price swings so hard, and what to check before you make any decisions.

For a deeper technical breakdown of the ticker itself, our NVOS stock price and analysis page is a good next stop after this one.

What Is Novo Integrated Sciences (NVOS)?

Novo Integrated Sciences is a healthcare and wellness company based in Bellevue, Washington, with the bulk of its clinical operations running through Canadian subsidiaries. The business splits into two main segments: Healthcare Services and Product Sales.

On the services side, Novo provides multidisciplinary primary care, including physiotherapy, occupational therapy, pain management, and rehabilitation for orthopedic and neurological conditions. It also runs eldercare programs through long-term care homes, retirement communities, and outpatient clinics. The product side focuses on wellness and diagnostic offerings tied to that same care network.

None of that is unusual for a small healthcare operator. What makes Novos stock a frequent search term is the trading behavior, not the business model.

Novos Stock (NVOS) Snapshot

Penny stocks like NVOS move fast, so treat the numbers below as a general reference rather than a live quote. Always pull a real-time price from your broker or a financial data provider before trading.

Why Does Novos Stock Swing So Much?

A few factors explain the wild single-day moves you will see on NVOS charts:

Low float and thin volume: With average daily volume often in the thousands of shares rather than millions, even a modest order can push the price sharply in either direction.

The 2023 reverse split: Novo executed a 1-for-10 reverse split in November 2023 to reduce its outstanding share count. Reverse splits often precede continued share price pressure if the underlying business hasn’t changed, and that pattern has played out here.

Dilution and financing needs: Small healthcare companies frequently raise cash by issuing new shares or convertible notes. That increases the share count and tends to weigh on price over time, even when operational news is neutral or positive.

OTC status: NVOS trades over the counter rather than on a major exchange like the Nasdaq or NYSE. OTC stocks generally have wider bid-ask spreads and less analyst coverage, both of which amplify volatility.

Retail sentiment: Message boards and social trading platforms drive a meaningful share of the volume on low-priced stocks. You can see this sentiment play out in real time on our NVOS Stocktwits roundup, which tracks community chatter around the ticker.

How to Check the Current Novos Stock Price

Because the price can move by double digits in a single session, don’t rely on a cached number from any article, including this one. Instead:

1. Pull a live quote from your brokerage app or a source like Nasdaq, Yahoo Finance, or Google Finance.
2. Check the 52-week range, not just the current price, to understand where today’s number sits historically.
3. Look at recent volume. A price jump on unusually low volume is a weaker signal than the same move on heavy trading.
4. Read the latest company filings and press releases directly from Novo Integrated Sciences rather than secondhand summaries.

Our companion piece, NVOS: Novo Integrated Sciences Price & Analysis, walks through how to read those signals together instead of in isolation.

What Moves Novo Integrated Sciences’ Business Fundamentals

Stock price aside, a few operational threads are worth watching if you’re tracking the company itself:

• Contract wins or losses with Canadian healthcare networks and long-term care facilities
• Progress on any licensing agreements involving its diagnostic or product lines
• Cash position and whether the company needs to raise capital again
• Management commentary on cost control, since healthcare services businesses run on thin margins

For a wider view of how the company has been positioned historically, see Navigating the Volatility: An Analysis of Novo Integrated Sciences Inc. Stock Price and Analyzing Novo Integrated Sciences (NVOS): A Comprehensive Overview, both of which cover the company’s operational history in more depth.

There’s also a related name worth knowing: Novosanis, a diagnostics-focused company sometimes confused with Novo Integrated Sciences because of the similar branding. Our breakdown of NVOS Stock: Analyzing the Potential of Novosanis in the Biotech Sector clears up that mix-up if you landed here looking for the wrong “Novo.”

Risks to Weigh Before Trading Novos Stock

This is general information, not investment advice, and you should treat it that way. A few risk points that apply specifically to a stock like NVOS:

• Delisting and compliance risk: OTC-listed penny stocks can face compliance issues that lead to trading halts or delisting.
• Dilution risk: Ongoing share issuance can erode existing shareholder value even if the company survives and grows.
• Liquidity risk: Thin trading volume means you might not be able to exit a position at the price you expect.
• Information gaps: Smaller OTC companies often have less analyst coverage and slower, less detailed public reporting than exchange-listed peers.

If any of that sounds unfamiliar, it’s worth reading up on how OTC markets work in general before placing a trade, not just this specific ticker, Visit more.

Novos Stock FAQs

Is “novos stock” the same as NVOS stock? 

Yes. “Novos stock” is a common misspelling of NVOS, the ticker symbol for Novo Integrated Sciences, Inc.

What exchange does NVOS trade on? 

NVOS trades on the OTC market rather than a major exchange like the Nasdaq or NYSE.

Why did NVOS do a reverse stock split? 

Novo Integrated Sciences completed a 1-for-10 reverse split in November 2023 to reduce its total outstanding share count, a move companies typically make to meet listing requirements or make the per-share price appear more stable.

Is NVOS a good long-term investment? 

That depends entirely on your own risk tolerance and research. NVOS carries the volatility, dilution, and liquidity risks common to small OTC healthcare stocks, so it belongs in the higher-risk part of any portfolio discussion, if at all. This article is informational and not financial advice.

Where can I find real-time NVOS stock data? 

Use a live source such as your brokerage platform, Nasdaq.com, Yahoo Finance, or Google Finance. Numbers published in articles, including this one, can be outdated within minutes given how thinly NVOS trades.

Is Novo Integrated Sciences related to Novosanis or Novo Nordisk? 

No. Despite similar-sounding names, these are separate companies. Novosanis is a diagnostics company, and Novo Nordisk is the large pharmaceutical company behind Ozempic. Novo Integrated Sciences is a separate, much smaller healthcare services business.

Conclusion

Novos stock, or more accurately NVOS, is a small, thinly traded OTC healthcare company whose share price has been shaped by a 2023 reverse split, ongoing dilution pressure, and the kind of low-float volatility that defines most penny stocks. The company’s underlying business, physiotherapy and eldercare services delivered mainly through Canadian subsidiaries, is fairly conventional. The stock chart is anything but.

If you’re researching NVOS, treat any single price point as a snapshot, not a forecast. Pull live data before you act, read the company’s own filings, and weigh the liquidity and dilution risks that come standard with OTC-listed shares. For continued coverage, check our NVOS stock analysis hub and Stocktwits sentiment tracker for updates as new information comes in.